David Ballingham
Physician Assistant · Harrisville, UTNPI 1821216722
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,250 of the $13,880 with a category attached, or 73.8%. AbbVie accounts for 81.7% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $11,946, more than ten times the $129 reported in 2021. Among physician assistant clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $84.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$11K
- Indivior Inc.$512
- Johnson & Johnson$484
- Teva Pharmaceuticals USA, Inc.$430
- Tris Pharma Inc$231
- Ironshore Pharmaceuticals Inc.$165
- plus $715 from 13 others
What the payments were for
- Speaking & faculty fees$10,25074%
- Travel & lodging$4563%
- Food & beverage$3,06222%
- Education$1111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$10,706
- UZEDY$122
- Dyanavel XR$104
How this compares
$13,880 in reported general payments places this provider in the 95th percentile of 1,543 physician assistant providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 18 | $5,272 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 18 | $4,713 |
| Lurasidone Hcl | 20 | $2,634 |
| Bupropion XlBupropion Hcl | 13 | $289 |
| Bupropion Hcl SrBupropion Hcl | 21 | $186 |
| Zolpidem Tartrate | 12 | $166 |
| Lamotrigine | 13 | $164 |
| Risperidone | 16 | $132 |
| Trazodone Hcl | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Suboxone | $512 | $5,27218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,543 physician assistant providers in Utah.
Other physician assistant in Harrisville
- Regan BrooksSlc$606K
- Keri HolyoakMidvale$438K
- Jill EricksonSalt Lake City$179K
- Vanessa Beard-ElyMurray$80K
- Natalie BeeSalt Lake City$63K
- Jasmin CharlesTaylorsville$46K
- Luke JenkinsWest Jordan$46K
- Chanise FrandsenSandy$31K
- Alexandra RoccoWashington Terrace$31K
- Jenna RhotonOgden$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.